Linked Life Data

15776276

Source:http://linkedlifedata.com/resource/pubmed/id/15776276

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15776276rdf:typepubmed:Citationlld:pubmed
pubmed-article:15776276lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:15776276lifeskim:mentionsumls-concept:C0014822lld:lifeskim
pubmed-article:15776276lifeskim:mentionsumls-concept:C0007806lld:lifeskim
pubmed-article:15776276lifeskim:mentionsumls-concept:C0031327lld:lifeskim
pubmed-article:15776276lifeskim:mentionsumls-concept:C0013125lld:lifeskim
pubmed-article:15776276pubmed:issue3lld:pubmed
pubmed-article:15776276pubmed:dateCreated2005-5-20lld:pubmed
pubmed-article:15776276pubmed:abstractTextErythropoietin (EPO) was originally described as a regulator of erythropoiesis. Recently, synthesis of EPO and expression of the EPO receptor (EPO-R) have been reported for the central nervous system (CNS). The potential use of EPO to prevent or reduce CNS injury and the paucity of information regarding its entry into the human CNS led us to examine the pharmacokinetics (PK) of recombinant human EPO (r-HuEPO) in the serum and cerebrospinal fluid (CSF).lld:pubmed
pubmed-article:15776276pubmed:languageenglld:pubmed
pubmed-article:15776276pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15776276pubmed:citationSubsetIMlld:pubmed
pubmed-article:15776276pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15776276pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15776276pubmed:statusMEDLINElld:pubmed
pubmed-article:15776276pubmed:monthMaylld:pubmed
pubmed-article:15776276pubmed:issn0031-6970lld:pubmed
pubmed-article:15776276pubmed:authorpubmed-author:CrumpMichaelMlld:pubmed
pubmed-article:15776276pubmed:authorpubmed-author:MessnerHans...lld:pubmed
pubmed-article:15776276pubmed:authorpubmed-author:LiptonJeffrey...lld:pubmed
pubmed-article:15776276pubmed:authorpubmed-author:KissThomas...lld:pubmed
pubmed-article:15776276pubmed:authorpubmed-author:XenocostasAna...lld:pubmed
pubmed-article:15776276pubmed:authorpubmed-author:LauCatherine...lld:pubmed
pubmed-article:15776276pubmed:authorpubmed-author:CheungWing...lld:pubmed
pubmed-article:15776276pubmed:authorpubmed-author:FarrellFranci...lld:pubmed
pubmed-article:15776276pubmed:authorpubmed-author:KelleyMarianMlld:pubmed
pubmed-article:15776276pubmed:authorpubmed-author:ZakszewskiCin...lld:pubmed
pubmed-article:15776276pubmed:authorpubmed-author:LutynskiAndrz...lld:pubmed
pubmed-article:15776276pubmed:issnTypePrintlld:pubmed
pubmed-article:15776276pubmed:volume61lld:pubmed
pubmed-article:15776276pubmed:ownerNLMlld:pubmed
pubmed-article:15776276pubmed:authorsCompleteYlld:pubmed
pubmed-article:15776276pubmed:pagination189-95lld:pubmed
pubmed-article:15776276pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:15776276pubmed:meshHeadingpubmed-meshheading:15776276...lld:pubmed
pubmed-article:15776276pubmed:meshHeadingpubmed-meshheading:15776276...lld:pubmed
pubmed-article:15776276pubmed:meshHeadingpubmed-meshheading:15776276...lld:pubmed
pubmed-article:15776276pubmed:meshHeadingpubmed-meshheading:15776276...lld:pubmed
pubmed-article:15776276pubmed:meshHeadingpubmed-meshheading:15776276...lld:pubmed
pubmed-article:15776276pubmed:meshHeadingpubmed-meshheading:15776276...lld:pubmed
pubmed-article:15776276pubmed:meshHeadingpubmed-meshheading:15776276...lld:pubmed
pubmed-article:15776276pubmed:meshHeadingpubmed-meshheading:15776276...lld:pubmed
pubmed-article:15776276pubmed:meshHeadingpubmed-meshheading:15776276...lld:pubmed
pubmed-article:15776276pubmed:meshHeadingpubmed-meshheading:15776276...lld:pubmed
pubmed-article:15776276pubmed:meshHeadingpubmed-meshheading:15776276...lld:pubmed
pubmed-article:15776276pubmed:meshHeadingpubmed-meshheading:15776276...lld:pubmed
pubmed-article:15776276pubmed:meshHeadingpubmed-meshheading:15776276...lld:pubmed
pubmed-article:15776276pubmed:year2005lld:pubmed
pubmed-article:15776276pubmed:articleTitleThe pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin.lld:pubmed
pubmed-article:15776276pubmed:affiliationHematology Division, Rm 2760, London Health Sciences Centre/University of Western Ontario, LHSC, Westminster Site, 800 Commissioners Road East, London, ON, N6A 4G5, Canada. anargyros.xenocostas@lhsc.on.calld:pubmed
pubmed-article:15776276pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15776276pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:15776276pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:15776276pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15776276lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15776276lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15776276lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15776276lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15776276lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15776276lld:pubmed